WELCOME TO MEDSHADOW. WE'VE UPDATED OUR LOOK!

Rare Peek into Internal FDA Furor: ARBs

FDA
FDA

The latest question before the FDA concerns the use of ARBs (angiotensin receptor blockers), when used primarily to manage hypertension.

Dr. Thomas Marciniak, FDA official, says the use of ARB-drugs seem to be linked somehow to an increase in the risk of lung cancer. Other FDA officials disagree and don’t want to promote/demand any further clinical or epidemiological studies.

What makes this issue interesting? Marciniak works for the FDA and has brought his concerns to the public, whose internal discussions are usually kept tight to the vest within the Agency. Literally millions of hypertensive patients are currently take ARBs. Sales of ARBs were $7.6 billion in the US last year. The FDA seems to be arguing over this matter as drug companies increase their profits and are not so interested in the long term effects that have a direct relationship to lung cancer.

The Wall Street Journal has some very awkward “quotes” from Dr. Unger about the lack of “enthusiasm” for a regulatory decision limiting or banning ARBs even if there were a 30% increased risk of cancer, as Marciniak postulates. The Wall Street Journal seems to support Marcinak’s David vs. Goliath stance.

This is a chance to see what happens when the FDA cannot make a decision. I’m also sure this lack of decision-making happens more often than the consumer wants to know about.

–MedShadow Staff

 

 

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x